Spero Europe Limited LONDON


Founded in 2015, Spero Europe, classified under reg no. 09738422 is an active company. Currently registered at 6th Floor EC2Y 5EB, London the company has been in the business for 9 years. Its financial year was closed on Tue, 31st Dec and its latest financial statement was filed on December 31, 2022.

The company has 2 directors, namely Patrick V., Ankit M.. Of them, Ankit M. has been with the company the longest, being appointed on 18 August 2015 and Patrick V. has been with the company for the least time - from 15 October 2015. As of 27 April 2024, there were 3 ex directors - Joel S., Stephen G. and others listed below. There were no ex secretaries.

Spero Europe Limited Address / Contact

Office Address 6th Floor
Office Address2 One London Wall
Town London
Post code EC2Y 5EB
Country of origin United Kingdom

Company Information / Profile

Registration Number 09738422
Date of Incorporation Tue, 18th Aug 2015
Industry Research and experimental development on biotechnology
End of financial Year 31st December
Company age 9 years old
Account next due date Mon, 30th Sep 2024 (156 days left)
Account last made up date Sat, 31st Dec 2022
Next confirmation statement due date Sat, 17th Aug 2024 (2024-08-17)
Last confirmation statement dated Thu, 3rd Aug 2023

Company staff

Patrick V.

Position: Director

Appointed: 15 October 2015

Ankit M.

Position: Director

Appointed: 18 August 2015

Joel S.

Position: Director

Appointed: 15 April 2019

Resigned: 08 November 2019

The Briars Group Limited

Position: Corporate Secretary

Appointed: 07 June 2016

Resigned: 05 October 2016

Stephen G.

Position: Director

Appointed: 18 August 2015

Resigned: 15 April 2019

Thomas P.

Position: Director

Appointed: 18 August 2015

Resigned: 02 July 2022

People with significant control

The register of PSCs who own or have control over the company includes 1 name. As we found, there is Spero Therapeutics, Inc from Cambridge, United States. The abovementioned PSC is categorised as "a public limited company", has 75,01-100% voting rights and has 75,01-100% shares. The abovementioned PSC has 75,01-100% voting rights and has 75,01-100% shares.

Spero Therapeutics, Inc

PO BOX 02139 675 Massachusetts Avenue, 14th Floor, Cambridge, Ma 02139, United States

Legal authority State Of Delaware
Legal form Public Limited Company
Country registered United States
Place registered Delaware
Registration number 333220858
Notified on 17 June 2017
Nature of control: 75,01-100% shares
75,01-100% voting rights
right to appoint and remove directors

Company filings

Filing category
Accounts Address Capital Confirmation statement Incorporation Officers Persons with significant control Resolution
Confirmation statement with no updates August 3, 2023
filed on: 5th, September 2023
Free Download (3 pages)

Company search

Advertisements